References
-
1
Broome U, Olsson R, Lööf L, et al.
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Gut.
1996;
38
610-5
-
2
Tamada K, Ueno N, Tomiyama T, et al.
Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy.
Gastrointest Endosc.
1998;
47
341-9
-
3
Dahlerup J F, Keiding S, Hansen S B, et al.
Detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by positron emission tomography (abstract).
Digestion.
1998;
59 (Suppl. 3)
26
-
4
Ponsioen C IJ, Vrouenraets S ME, van Milligen de Wit A WM, et al.
Value of brush border cytology for dominant strictures in primary sclerosing cholangitis.
Endoscopy.
1999;
31
305-9
-
5
Rizzi P M, Portman B, Ramage J K, et al.
p53 protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
Gut.
1996;
38
265-8
-
6 Hultcrantz R, Olson R, Danielson A, et al. J Hepatol 1999 30: 669-73
-
7
Luftus E V, Aguilar H J, Sandborn W, et al.
Risk of colorectal neoplasia in patients with primary biliary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Hepatology.
1998;
27
685-90
-
8
Lindor K D, Mayo PSC/UDCA Study Group.
Ursodiol for the treatment of primary sclerosing cholangitis.
N Engl J Med.
1997;
336
691-5
-
9
Stiehl A, Rudolph G, Sauer P, et al.
Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis: an 8-year prospective study.
J Hepatol.
1997;
26
560-6
A. StiehlM.D.
Klinikum der Ruprecht-Karls-Universität
Bergheimstrasse 58
69115 Heidelberg
Germany
Phone: + 49-6221-565687
Email: adolf_stiehl@Krzmail.krz.uni-heidelberg.de